Rare diseases
Investigational molecules
Locations
706 conditions with trials, the busiest first
3 924 trials across Europe, recruiting first
A study of tovorafenib for children and young adults with newly diagnosed or recurrent craniopharyngioma
FranceUsing focused ultrasound to improve temozolomide treatment for patients with diffuse midline glioma
The NetherlandsComparison of dupilumab and tezepelumab for the treatment of chronic rhinosinusitis with nasal polyps.
AustriaStudy of osimertinib and febuxostat to improve drug delivery in patients with EGFR-mutated non-small cell lung cancer without brain metastases
The NetherlandsA study of ipilimumab and nivolumab to observe immune system changes in patients with unresectable stage III or IV melanoma
The NetherlandsA study to evaluate the safety and effectiveness of AZD9793 in adults with advanced or metastatic liver cancer
SpainA study to evaluate the safety and effectiveness of oxaliplatin delivered directly to the liver for patients with colorectal cancer and liver metastasis
BelgiumA study to evaluate the safety and effectiveness of PTT-4256 and nivolumab in patients with solid tumors.
FranceA study to evaluate if silymarin prevents liver damage caused by ribociclib in patients with hormone receptor positive, HER2-negative breast cancer
ItalyA study of irinotecan, fluorouracil, calcium folinate, zimberelimab, and domvanalimab for patients with metastatic gastro-enteropancreatic neuroendocrine carcinoma.
FranceComparing the timing of etoposide and dexamethasone treatment for patients with severe sporadic hemophagocytic lymphohistiocytosis in intensive care.
FranceA study to evaluate the safety of SGN-ALPV in patients with advanced solid tumors
The NetherlandsThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
